Chipayo-Gonzales David, Ramakrishna Harish, Nuñez-Gil Ivan J
Division of Interventional Cardiology, Cardiovascular Institute, Hospital Clinico San Carlos, Madrid, Spain.
Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester Minnesota, MN.
J Cardiothorac Vasc Anesth. 2022 Jan;36(1):18-21. doi: 10.1053/j.jvca.2021.09.033. Epub 2021 Sep 24.
The recently published guidelines of the European Society of Cardiology for the prevention of cardiovascular diseases presented in August 2021 at the virtual European Society of Cardiology congress recommend the use of the SCORE2 risk index instead of the classic SCORE risk index to calculate the cardiovascular risk (specifically, ten-year fatal and nonfatal risk) in a healthy population under the age of 70 years, with a level of evidence IB. This new risk index was developed with the collaboration of about 200 investigators, including 45 cohorts in 13 countries with 700,000 participants, and covers the known risk factors for heart and circulatory diseases such as age, sex, lipid levels, blood pressure, and smoking. In addition, it divides the countries into four groups of risk and uses a competing risk model, adjusting the risk for the probability of having another event, which enables better estimation of the risk of fatal and nonfatal events in a younger population (40-69 years).
欧洲心脏病学会于2021年8月在虚拟的欧洲心脏病学会大会上发布的心血管疾病预防指南推荐使用SCORE2风险指数而非经典的SCORE风险指数,来计算70岁以下健康人群的心血管风险(具体为十年致死和非致死风险),证据等级为IB。这个新的风险指数是在约200名研究人员的合作下开发的,其中包括来自13个国家的45个队列、70万名参与者,涵盖了已知的心脏和循环系统疾病风险因素,如年龄、性别、血脂水平、血压和吸烟情况。此外,它将各国分为四组风险类别,并使用竞争风险模型,根据发生其他事件的概率调整风险,从而能够更好地估计年轻人群(40 - 69岁)致死和非致死事件的风险。